| J9271 | Injection, pembrolizumab, 1 mg | 7,700 | $40 | $331.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,400 | $40 | $205.2K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,210 | $30 | $75.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $90 | $48.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 310 | $130 | $41.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $110 | $33.1K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,510 | $20 | $31.7K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 370 | $70 | $26.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12,550 | $1 | $25.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $60 | $25K |